Multiomics Analyses to Deliver the Most Effective Treatment to Every Patient With Inflammatory Bowel Disease

Gastroenterology. 2018 Nov;155(5):e1-e4. doi: 10.1053/j.gastro.2018.07.039. Epub 2018 Aug 2.

IBD Multi Omics Consortium:
R K Weersma, J C Barrett, S Vermeire, R J Xavier, C A Anderson, C Wijmenga, M J Daly, E J Alm, J Raes, C Huttenhower, T Stappenbeck, M Netea, A Kaser, A Franke, D P McGovern, J F Colombel, G R van den Brink, H H Uhlig, M Georges, C W Lees, M Parkes, C Giallourakis, A Hart, J D Rioux, H Sokol, A Hurtado-Lorenzo, G Yeretssian, M L Markus-de Kwaadsteniet, E A Festen, S Rahmouni, S Vieira-Silva, R E McIntyre, L Moutsianas

¹ University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, the Netherlands.
² Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, Massachusetts; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
³ University of Leuven and University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven Belgium.
⁴ Genomics plc, Oxford, United Kingdom.

No abstract available

Publication types